SF3B1 and myelodysplastic syndrome: Mutations in SF3B1 have also been reported in myelodysplastic syndromes (MDS) as well as numerous cancers, including acute myeloid leukemia, primary myelofibrosis, chronic myelomonocytic leukemia (CML)12, chronic lymphocytic leukemia (CLL)13, 14, multiple myeloma, uveal melanoma15, 16, 17, 18 and breast cancers19, 20, 21.